Griffith J - Search Results

1

Matching-Adjusted Indirect Comparison Between Risankizumab and Ustekinumab for Induction and Maintenance Treatment of Moderately to Severely Active Crohn's Disease.

Dubinsky M, Ma C, Griffith J, Crowell M, Neimark E, Kligys K, O'Connell T. Dubinsky M, et al. Among authors: griffith j. Adv Ther. 2023 Sep;40(9):3896-3911. doi: 10.1007/s12325-023-02546-6. Epub 2023 Jun 27. Adv Ther. 2023. PMID: 37368103 Free PMC article. Clinical Trial.

2

Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn's Disease.

Loftus EV Jr, Griffith J, Neimark E, Song A, Wallace K, Nannapaneni S, Zhou J, Byrne R, Kligys K, Pang Y, Liao X, Kalabic J, Dubinsky M. Loftus EV Jr, et al. Among authors: griffith j. Adv Ther. 2023 May;40(5):2311-2325. doi: 10.1007/s12325-023-02477-2. Epub 2023 Mar 14. Adv Ther. 2023. PMID: 36917429 Free PMC article. Clinical Trial.

3

Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn's Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 Studies.

Colombel JF, Schreiber S, D'Haens G, Rizzo J, Kligys K, Griffith J, Zambrano J, Zhou Q, Zhang Y, Kalabic J, Rieder F, Dubinsky M, Panaccione R. Colombel JF, et al. Among authors: griffith j. J Crohns Colitis. 2023 Dec 9:jjad206. doi: 10.1093/ecco-jcc/jjad206. Online ahead of print. J Crohns Colitis. 2023. PMID: 38069472

4

Economic Burden of Switching to a Non-Tumor Necrosis Factor Inhibitor Versus a Tumor Necrosis Factor Inhibitor Biologic Therapy among Patients with Rheumatoid Arthritis.

Zhou ZY, Griffith J, Du EX, Chin D, Betts KA, Ganguli A. Zhou ZY, et al. Among authors: griffith j. Adv Ther. 2016 May;33(5):807-23. doi: 10.1007/s12325-016-0318-5. Epub 2016 Mar 24. Adv Ther. 2016. PMID: 27084724

5

Network Meta-Analysis and Cost Per Responder of Tumor Necrosis Factor-α and Interleukin Inhibitors in the Treatment of Active Ankylosing Spondylitis.

Betts KA, Griffith J, Song Y, Mittal M, Joshi A, Wu EQ, Ganguli A. Betts KA, et al. Among authors: griffith j. Rheumatol Ther. 2016 Dec;3(2):323-336. doi: 10.1007/s40744-016-0038-y. Epub 2016 Jul 25. Rheumatol Ther. 2016. PMID: 27747581 Free PMC article.

6

Economic Evaluation of Timely Versus Delayed Use of Tumor Necrosis Factor Inhibitors for Treatment of Psoriatic Arthritis in the US.

Strand V, Husni E, Griffith J, Zhou ZY, Signorovitch J, Ganguli A. Strand V, et al. Among authors: griffith j. Rheumatol Ther. 2016 Dec;3(2):305-322. doi: 10.1007/s40744-016-0042-2. Epub 2016 Sep 15. Rheumatol Ther. 2016. PMID: 27747584 Free PMC article.

7

Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry.

Pappas DA, Kremer JM, Griffith J, Reed G, Salim B, Karki C, Garg V. Pappas DA, et al. Among authors: griffith j. Rheumatol Ther. 2017 Dec;4(2):375-389. doi: 10.1007/s40744-017-0077-z. Epub 2017 Aug 24. Rheumatol Ther. 2017. PMID: 28840531 Free PMC article.

8

An indirect comparison and cost per responder analysis of adalimumab, methotrexate and apremilast in the treatment of methotrexate-naïve patients with psoriatic arthritis.

Betts KA, Griffith J, Friedman A, Zhou ZY, Signorovitch JE, Ganguli A. Betts KA, et al. Among authors: griffith j. Curr Med Res Opin. 2016;32(4):721-9. doi: 10.1185/03007995.2016.1140026. Epub 2016 Jan 25. Curr Med Res Opin. 2016. PMID: 26743448 Review.

9

A Retrospective Analysis of Corticosteroid Utilization Before Initiation of Biologic DMARDs Among Patients with Rheumatoid Arthritis in the United States.

Spivey CA, Griffith J, Kaplan C, Postlethwaite A, Ganguli A, Wang J. Spivey CA, et al. Among authors: griffith j. Rheumatol Ther. 2018 Jun;5(1):255-270. doi: 10.1007/s40744-017-0089-8. Epub 2017 Dec 4. Rheumatol Ther. 2018. PMID: 29204858 Free PMC article.

10

Economic Burden of Switching to Different Biologic Therapies Among Tumor Necrosis Factor Inhibitor-Experienced Patients with Psoriatic Arthritis.

Song Y, Betts KA, Lu Y, Singh R, Clewell J, Griffith J. Song Y, et al. Among authors: griffith j. Rheumatol Ther. 2019 Jun;6(2):285-297. doi: 10.1007/s40744-019-0158-2. Epub 2019 May 4. Rheumatol Ther. 2019. PMID: 31055779 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,283 results

Search Page